Taylor Morrison Home Statistics
Total Valuation
TMHC has a market cap or net worth of $5.78 billion. The enterprise value is $7.67 billion.
| Market Cap | 5.78B |
| Enterprise Value | 7.67B |
Important Dates
The last earnings date was Wednesday, October 22, 2025, before market open.
| Earnings Date | Oct 22, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TMHC has 97.73 million shares outstanding. The number of shares has decreased by -5.02% in one year.
| Current Share Class | 97.73M |
| Shares Outstanding | 97.73M |
| Shares Change (YoY) | -5.02% |
| Shares Change (QoQ) | -0.87% |
| Owned by Insiders (%) | 0.60% |
| Owned by Institutions (%) | 101.23% |
| Float | 97.10M |
Valuation Ratios
The trailing PE ratio is 7.11 and the forward PE ratio is 9.24.
| PE Ratio | 7.11 |
| Forward PE | 9.24 |
| PS Ratio | 0.71 |
| Forward PS | 0.77 |
| PB Ratio | 0.93 |
| P/TBV Ratio | 1.05 |
| P/FCF Ratio | 10.14 |
| P/OCF Ratio | 9.49 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.79, with an EV/FCF ratio of 13.46.
| EV / Earnings | 9.02 |
| EV / Sales | 0.92 |
| EV / EBITDA | 5.79 |
| EV / EBIT | 5.97 |
| EV / FCF | 13.46 |
Financial Position
The company has a current ratio of 7.99, with a Debt / Equity ratio of 0.37.
| Current Ratio | 7.99 |
| Quick Ratio | 0.63 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | 1.69 |
| Debt / FCF | 3.97 |
| Interest Coverage | 31.37 |
Financial Efficiency
Return on equity (ROE) is 14.40% and return on invested capital (ROIC) is 9.79%.
| Return on Equity (ROE) | 14.40% |
| Return on Assets (ROA) | 8.49% |
| Return on Invested Capital (ROIC) | 9.79% |
| Return on Capital Employed (ROCE) | 14.91% |
| Revenue Per Employee | $2.79M |
| Profits Per Employee | $283,646 |
| Employee Count | 3,000 |
| Asset Turnover | 0.89 |
| Inventory Turnover | 0.97 |
Taxes
In the past 12 months, TMHC has paid $263.37 million in taxes.
| Income Tax | 263.37M |
| Effective Tax Rate | 23.48% |
Stock Price Statistics
The stock price has decreased by -13.76% in the last 52 weeks. The beta is 1.61, so TMHC's price volatility has been higher than the market average.
| Beta (5Y) | 1.61 |
| 52-Week Price Change | -13.76% |
| 50-Day Moving Average | 65.04 |
| 200-Day Moving Average | 62.07 |
| Relative Strength Index (RSI) | 35.97 |
| Average Volume (20 Days) | 1,359,309 |
Short Selling Information
The latest short interest is 3.66 million, so 3.74% of the outstanding shares have been sold short.
| Short Interest | 3.66M |
| Short Previous Month | 3.77M |
| Short % of Shares Out | 3.74% |
| Short % of Float | 3.76% |
| Short Ratio (days to cover) | 3.42 |
Income Statement
In the last 12 months, TMHC had revenue of $8.38 billion and earned $850.94 million in profits. Earnings per share was $8.31.
| Revenue | 8.38B |
| Gross Profit | 2.03B |
| Operating Income | 1.29B |
| Pretax Income | 1.12B |
| Net Income | 850.94M |
| EBITDA | 1.32B |
| EBIT | 1.29B |
| Earnings Per Share (EPS) | $8.31 |
Balance Sheet
The company has $370.59 million in cash and $2.26 billion in debt, giving a net cash position of -$1.89 billion or -$19.37 per share.
| Cash & Cash Equivalents | 370.59M |
| Total Debt | 2.26B |
| Net Cash | -1.89B |
| Net Cash Per Share | -$19.37 |
| Equity (Book Value) | 6.20B |
| Book Value Per Share | 63.29 |
| Working Capital | 7.04B |
Cash Flow
In the last 12 months, operating cash flow was $609.16 million and capital expenditures -$39.30 million, giving a free cash flow of $569.86 million.
| Operating Cash Flow | 609.16M |
| Capital Expenditures | -39.30M |
| Free Cash Flow | 569.86M |
| FCF Per Share | $5.83 |
Margins
Gross margin is 24.23%, with operating and profit margins of 15.34% and 10.16%.
| Gross Margin | 24.23% |
| Operating Margin | 15.34% |
| Pretax Margin | 13.39% |
| Profit Margin | 10.16% |
| EBITDA Margin | 15.81% |
| EBIT Margin | 15.34% |
| FCF Margin | 6.80% |
Dividends & Yields
TMHC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 5.02% |
| Shareholder Yield | 5.02% |
| Earnings Yield | 14.72% |
| FCF Yield | 9.86% |
Analyst Forecast
The average price target for TMHC is $78.88, which is 33.38% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $78.88 |
| Price Target Difference | 33.38% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TMHC has an Altman Z-Score of 4.05 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.05 |
| Piotroski F-Score | 5 |